Scholarship on international health law is currently pushing the boundaries while taking stock of achievements made over the past few decades. However despite the forward thinking approach of scholars working in the field of global health one area remains a stumbling block in the path to...

Virtually all fiscal measures influence people's health, through their impacts on behaviour, consumption, income and wealth. A narrow subset of fiscal measures, however, can be more directly aimed at improving health by targeting behaviours and risks that are known to be strongly associated with...

A large literature examines the connection between the size and scope of government in the industrial democracies and human well-being, and generally demonstrates that greater government intervention into the market economy promotes higher levels of life satisfaction. In this paper, we extend...

"The global movement toward universal health coverage (UHC) is accompanied by requests for large increases in government health spending in some countries. This, combined with the global economic situation and stagnant economic growth across many low- and middle-income countries, makes it more...

Front Cover -- Contents -- Acknowledgments -- About the Author -- Abbreviations -- Chapter 1 Introduction -- Background -- Objectives of the Guidance Note -- Chapter 2 Objectives of Health Financing Policy Dialogue -- Objectives -- The Starting Point -- Unpacking the Health Financing Challenges...

The global movement toward universal health coverage (UHC) is accompanied by requests for large increases in government health spending in some countries. This combined with the global economic situation and stagnant economic growth across many low- and middle-income countries make it more...

The portfolio approach of financing drug development has been proposed as a financial innovation to improve the risk/return tradeoff of investment in drug development projects through the use of diversification and securitization. By investing in a sizable and well-diversified portfolio of novel...

Recent outbreaks of infectious pathogens such as Zika, Ebola, and COVID-19 have underscored the need for the dependable availability of vaccines against emerging infectious diseases (EIDs). The cost and risk of R&D programs and uniquely unpredictable demand for EID vaccines have discouraged...